United States · FDA National Drug Code directory
Epoprostenol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68083-707_8b45ebae-92d6-4a3b-a559-115c66a8352a
- Product NDC
- 68083-707
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Epoprostenol
- Labeler
- Gland Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251229
- Source listing expiry
- 20271231
Source-listed ingredients
- EPOPROSTENOL — .5 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (68083-707-01) / 10 mL in 1 VIAL · 68083-707-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →